OBJECTIVES: Isometric handgrip (IHG) training (four, 2-min sustained contractions at 30% of maximal voluntary contraction, three times per week for 8-10 weeks) lowers resting arterial blood pressure (BP) in hypertensive patients, including those receiving pharmacotherapy, although the mechanisms remain elusive. Ambulatory BP measurements are more efficacious in predicting cardiovascular disease-related events, yet the effects of IHG training on ambulatory BP are unknown. The objective of the current investigation was to test the hypotheses that 8 weeks of IHG training lowers resting and 24 h ambulatory BP concomitantly in medicated hypertensive patients, and may be the result of improved vagal modulation. METHODS: BP was assessed using brachial artery oscillometry, and coarse-graining spectral analysis was used to determine spectral power. Resting and 24 h ambulatory BP and heart rate variability (HRV) were measured pretraining, midtraining, and post-training in 11 medicated hypertensive patients (mean ± SD, resting BP: 113.9 ± 12.7/60.7 ± 11.6 mmHg), and in nine medicated hypertensive controls (resting BP: 117.8 ± 14.3/67.5 ± 4.2 mmHg). RESULTS: Indices of BP and HRV were not significantly altered with IHG training (all P > 0.05). CONCLUSION: IHG training does not lower resting or ambulatory BP in hypertensive patients successfully treated with pharmacotherapy to within the normal range (≤ 120/80 mmHg), nor does it improve HRV. Future studies should examine alternative IHG training protocols in well-managed hypertensive patients and/or target poorly controlled medicated hypertensive patients.
OBJECTIVES: Isometric handgrip (IHG) training (four, 2-min sustained contractions at 30% of maximal voluntary contraction, three times per week for 8-10 weeks) lowers resting arterial blood pressure (BP) in hypertensivepatients, including those receiving pharmacotherapy, although the mechanisms remain elusive. Ambulatory BP measurements are more efficacious in predicting cardiovascular disease-related events, yet the effects of IHG training on ambulatory BP are unknown. The objective of the current investigation was to test the hypotheses that 8 weeks of IHG training lowers resting and 24 h ambulatory BP concomitantly in medicated hypertensivepatients, and may be the result of improved vagal modulation. METHODS: BP was assessed using brachial artery oscillometry, and coarse-graining spectral analysis was used to determine spectral power. Resting and 24 h ambulatory BP and heart rate variability (HRV) were measured pretraining, midtraining, and post-training in 11 medicated hypertensivepatients (mean ± SD, resting BP: 113.9 ± 12.7/60.7 ± 11.6 mmHg), and in nine medicated hypertensive controls (resting BP: 117.8 ± 14.3/67.5 ± 4.2 mmHg). RESULTS: Indices of BP and HRV were not significantly altered with IHG training (all P > 0.05). CONCLUSION: IHG training does not lower resting or ambulatory BP in hypertensivepatients successfully treated with pharmacotherapy to within the normal range (≤ 120/80 mmHg), nor does it improve HRV. Future studies should examine alternative IHG training protocols in well-managed hypertensivepatients and/or target poorly controlled medicated hypertensivepatients.
Authors: Philip J Millar; Cheri L McGowan; Véronique A Cornelissen; Claudio G Araujo; Ian L Swaine Journal: Sports Med Date: 2014-03 Impact factor: 11.136
Authors: Cheri L McGowan; David N Proctor; Ian Swaine; Robert D Brook; Elizabeth A Jackson; Phillip D Levy Journal: Curr Hypertens Rep Date: 2017-06 Impact factor: 5.369
Authors: Mark B Badrov; Cassandra L Bartol; Matthew A DiBartolomeo; Philip J Millar; Nancy H McNevin; Cheri L McGowan Journal: Eur J Appl Physiol Date: 2013-04-16 Impact factor: 3.078
Authors: Jodie D Inder; Deborah J Carlson; Gudrun Dieberg; James R McFarlane; Nicole Cl Hess; Neil A Smart Journal: Hypertens Res Date: 2015-10-15 Impact factor: 3.872
Authors: Garrett I Ash; Beth A Taylor; Paul D Thompson; Hayley V MacDonald; Lauren Lamberti; Ming-Hui Chen; Paulo Farinatti; William J Kraemer; Gregory A Panza; Amanda L Zaleski; Ved Deshpande; Kevin D Ballard; Mohammadtokir Mujtaba; C Michael White; Linda S Pescatello Journal: J Hypertens Date: 2017-02 Impact factor: 4.844